RECRUITINGINTERVENTIONAL

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients

About This Trial

This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-CABG (coronary artery bypass grafting) patients or post-PCI (percutaneous coronary intervention) patients. A randomized controlled trial design will be used, involving approximately 5-10 hospitals and 536 participants. Eligible participants are adults aged 18 or older, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.

Who May Be Eligible (Plain English)

Who May Qualify: - Age ≥ 18 years. - History of CABG surgery or PCI with history of hypertension, diabetes, and dyslipidemia. - At least one of the following criteria is meet: - Systolic blood pressure no less than 130 mmHg or diastolic blood pressure no less than 80 mmHg - HbA1c no less than 7% - LDL-C no less than 1.4 mmol/L - Use of a smartphone. - Signed willing to sign a consent form. Who Should NOT Join This Trial: - History of heart failure or severe arrhythmias. - Presence of other severe underlying conditions such as cancer or liver and kidney insufficiency. - Pregnancy, lactation, or plans for pregnancy within the next year. - Cognitive, communication impairments, or limitations in daily activities. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Age ≥ 18 years. * History of CABG surgery or PCI with history of hypertension, diabetes, and dyslipidemia. * At least one of the following criteria is meet: * Systolic blood pressure no less than 130 mmHg or diastolic blood pressure no less than 80 mmHg * HbA1c no less than 7% * LDL-C no less than 1.4 mmol/L * Use of a smartphone. * Signed informed consent. Exclusion Criteria: * History of heart failure or severe arrhythmias. * Presence of other severe underlying conditions such as cancer or liver and kidney insufficiency. * Pregnancy, lactation, or plans for pregnancy within the next year. * Cognitive, communication impairments, or limitations in daily activities.

Treatments Being Tested

BEHAVIORAL

Smart family doctor

Based on health managers, participants were additionally provided "Smart family doctor", which is an AI-assisted applications with personalized interactions. The content includes, but is not limited to: (1) General educational content, covering basic health knowledge on diseases, risk factors, and treatment methods; (2) Targeted health information, such as more specific guidance on blood pressure and blood sugar control, medication adherence, exercise, and smoking cessation; (3) Personalized disease management guidance, providing tailored reminders for patients regarding medication, diet, exercise, and medical visits. Patients can also directly report their latest self-measured blood pressure, blood lipid, blood sugar levels, and medication adherence to receive treatment and medication guidance from the 'Smart family doctor'.

BEHAVIORAL

Health manager

Participants will received 3-hour health management guidance from a health manager once a week, including guidance on healthy lifestyle, medication treatment, and rehabilitation advice. The research team will provide participants with one smart band, requiring them to wear the band daily to collect health data during the 6-month study period.

Locations (1)

Xinjiang's First Affiliated Hospital of medical university

Ürümqi, Xinjiang, China